Advertisement

Mortality among the Least Frail: Lessons from Research on the APOE GENE

  • Douglas C. Ewbank
Part of the International Studies in Population book series (ISIP, volume 4)

Until recently, most research on the factors associated with mortality among adults was limited to the ages under 85. Now we find that mortality is declining rapidly over age 85 (Wilmoth et al. 2000) and the number of centenarians is increasing at a surprising rate. These trends have led to uncertainty about the prospects for further improvements in survival at the oldest ages. Recent research on health and mortality over age 85 suggests that the oldest-old may be different in many ways from the younger-old. Some of the physiological risk factors that are well established for those under age 85 may not work in the same way at the oldest ages. One reason for this is that survivors to the oldest ages are on average more robust (less frail) than average. That is, they have a lower frequency of risk factors for causes of premature mortality. Studying how risk factors change with age introduces several methodologically difficult issues. It requires new demographic and statistical approaches that model changes in the relative risks with age. It may also require different approaches to data collection and publication of results. Since few studies will be large enough to answer these questions, there is an increasing need for meta-analyses that combine data from numerous studies.

Keywords

Life Table Unobserved Heterogeneity APOE Genotype APOE Gene Estimate Relative Risk 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., and Pericak-Vance, M. A. (1993) “Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families”, Science, 261(5123):921-923.CrossRefGoogle Scholar
  2. Corder, E. H., Lannfelt, L., Viitanen, M., Corder, L. S., Manton, K. G., Bengt, W., and Hans, B. (1996) “Apolipoprotein E genotype determines survival in the oldest old (85 years or older) who have good cognition”, Archives of Neurology, 53(5):418-422.Google Scholar
  3. Eggertsen, G., Tegelman, R., Ericsson, S., Angelin, B., and Berglund, L. (1993) “Apolipoprotein E polymorphism in a healthy Swedish population: variation of allele frequency with age and relation to serum lipid concentrations”, Clinical Chemistry, 39(10):2125-2129.Google Scholar
  4. Ewbank, D. C. (2001) “Demography in the age of genomics: A first look at the prospects”. In Finch: C. E., Vaupel, J. W., and Kinsella, K. (eds.), Cells and Surveys. Washington, D.C.: National Academy Press, pp. 64-109.Google Scholar
  5. Ewbank, D. C. (2002) “Mortality differences by APOE genotype estimated from demographic synthesis”, Genetic Epidemiology, 22(2):146-155.CrossRefGoogle Scholar
  6. Ewbank, D. C. (2004) “The APOE gene and differences in life expectancy in Europe”, Journal of Gerontology: Series A Biological Science and Medical Science, 59A(1):8-12.Google Scholar
  7. Farrer, L. A., Cripples, L. A., Haines, J. L., Hyman, B., Kukull, W. A., Mayeux, R., Myers, R. H., PericakVance, M. A., Risch, N., van Duijn, C. M., and APOE and Alzheimer Disease Meta Analysis Consortium (1997) “Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease”, JAMA, 278 (16):1349-1356.CrossRefGoogle Scholar
  8. Fillenbaum, G. G., Landerman, L. R., Blazer, D. G., Saunders, A. M., Harris, T. B., and Launer, L. J. (2001) “The relationship of APOE genotype to cognitive functioning in older African-American and Caucasian community residents”, Journal of the American Geriatrics Society, 49(9):1148-1155.CrossRefGoogle Scholar
  9. Fullerton, S. M., Clark, A. G., Weiss, K. M., Nickerson, D. A., Taylor, S. L., Steng ård, J. H., Salomaa V., Vartiainen, E., Perola, M., Boerwinkle, E., and Sing, C. F. (2000) “Apolipoprotein E variation at the sequence haplotype level: Implications for the origin and maintenance of a major human polymorphism”, American Journal of Human Genetics, 67(4):881-900.CrossRefGoogle Scholar
  10. Gerdes, L. U., Klausen, I. C., Sihm, I., and Færgeman, O. (1992) “Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world”, Genetic Epidemiology, 9:155-157.CrossRefGoogle Scholar
  11. Gerdes, L. U., Jeune, B., Ranberg, K. A., Nybo, H., and Vaupel, J. W. (2000) “Estimation of Apolipoprotem E genotypespecific relative mortality risks from the distribution of genotypes in centenarians and middle-age men: Apolipoprotein E gene is a ‘frailty gene’, not a ‘longevity gene”’, Genetic Epidemiology, 19(3):202-210.CrossRefGoogle Scholar
  12. Hixson, J. E. (1991) “Apolipoprotein E polymorphisms affect atherosclerosis in young males. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) research group”, Arteriosclerosis and Thrombosis, 11(5):1237-1244.Google Scholar
  13. Jian-Gang, Z., Yong-Xing, M., Chuan-Fu, W., Pei-Fang, L., Song-Bai, Z., Nui-Fan, G., Guo-Yin, F., and Lin, H. (1998) “Apolipoprotin E and longevity among Han Chinese population”, Mechanisms of Ageing and Development, 104:159-167.CrossRefGoogle Scholar
  14. Juva, K., Verkkoniemi, A., Viramo, P., Polvikoski, T., Kainulainen, K., Kontula, K., and Sulkava, R. (2000) “APOE epsilon 4 does not predict mortality, cognitive decline, or dementia in the oldest old”, Neurology, 54(2):412-415.Google Scholar
  15. Lee, J. H., Tang, M. X., Schupf, N., Stern, Y., Jacobs, D. M., Tycko, B., and Mayeux, R. (2001) “Mortality and apolipoprotein e in Hispanic, African-American, and Caucasian elders”, American Journal of Medical Genetics, 103 (2):121-127.CrossRefGoogle Scholar
  16. Manton, K. G., Stallard, E., and Vaupel, J. W. (1986) “Alternative models for the heterogeneity of mortality risks among the aged”, JASA, 81(395):635-644.Google Scholar
  17. Skoog, I., Hesse, C., Aevarsson, O., Landahl, S., Wahlstrom, J., Fredman, P., and Blennow, K. (1998) “A population study of apoe genotype at the age of 85: Relation to dementia, cerebrovascular disease, and mortality”, Journal of Neurology, Neurosurgery and Psychiatry, 64(1):37-43.CrossRefGoogle Scholar
  18. Srinivasan, S. R., Ehnholm, C., Wattigney, W. A., Bao, W., and Berenson, G. S. (1996) “The relation of apolipopro-tein E polymorphism to multiple cardiovascular risk in children: The Bogalusa Heart Study”, Atherosclerosis, 123 (1-2):33-42.CrossRefGoogle Scholar
  19. Steng ård, J. H., Weiss, K. M., and Sing, C. F. (1998) “An ecological study of association between coronary heart disease mortality rates in men and the relative frequencies of common allelic variations in the gene coding for apolipoprotein E”, Human Genetics, 103(2):234-41.CrossRefGoogle Scholar
  20. Tilvis, R. S., Strandberg, T. E., and Juva, K. (1998) “Apolipoprotein E phenotypes, dementia and mortality in a prospective population sample”, Journal of the American Geriatrics Society, 46(6):712-715.Google Scholar
  21. van Bockxmeer, F. M., and Mamotte, C. D. (1992) “Apolipoprotein E4 homozygosity in young men with coronary heart disease”, Lancet, 340(8824):879-880.CrossRefGoogle Scholar
  22. Vaupel, J. W., Manton, K. G., and Stallard, E. (1979) “The impact of heterogeneity on individual frailty on the dynamics of mortality”, Demography, 16:439-454.CrossRefGoogle Scholar
  23. Vogt, M. T., Cauley, J. A., and Kuller, L. H. (1997) “Apolipoprotein A phenotype, arterial disease, and mortality among older women: The study of osteoporotic fractures”, Genetic Epidemiology, 14(2):147-156.CrossRefGoogle Scholar
  24. Wilson, P. W. F., Schaefer, E. J., Larson, M. G., and Ordovas, J. M. (1996) “Apolipoprotein E alleles and risk of coronary disease: A meta-analysis”, Arteriosclerosis, Thrombosis, and Vascular Biology, 16:1250-1255.Google Scholar
  25. Wilmoth, J. R., Deegan, L. J., Lundrstrom, H., and Horiuchi, S. (2000) “Increase of maximum life-span in Sweden, 1861-1999”, Science, 289(5488):2366-2368.CrossRefGoogle Scholar
  26. Yashin, A. I., De Benedictis, G., Vaupel, J. W., Tan, Q., Andreev, K. F., Iachine, I. A., Bonafe, M., DeLuca, M., Valensin, S., Carotenuto, L., and Franceschi, C. (1999) “Genes, demography and life span: The contribution of demographic data in genetic studies of aging and longevity”, American Journal of Human Genetics, 65:1178-1193.CrossRefGoogle Scholar

Copyright information

© Springer 2007

Authors and Affiliations

  • Douglas C. Ewbank
    • 1
  1. 1.Population Studies CentreUniversity of PennsylvaniaUSA

Personalised recommendations